{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:30:01Z","timestamp":1793399401246,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Syngenta Ltd. Jealott\u2019s Hill International Research Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.toxlet.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T11:51:04Z","timestamp":1428753064000},"page":"189-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines"],"prefix":"10.1016","volume":"235","author":[{"given":"Abigail M.","family":"Dalzell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith. M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin. D.A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2015.04.005_bib0005","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1124\/dmd.112.044719","article-title":"Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp\/Bcrp knockout mice","volume":"40","author":"Agarwal","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0010","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuropharm.2006.07.038","article-title":"Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein","volume":"52","author":"Baltes","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.toxlet.2015.04.005_bib0020","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1128\/MCB.9.10.4337","article-title":"Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid induced differentiation","volume":"9","author":"Bates","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11259-007-9007-9","article-title":"Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers","volume":"32","author":"Brayden","year":"2008","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0030","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1158\/0008-5472.CAN-04-2416","volume":"65","author":"Breedveld","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0035","doi-asserted-by":"crossref","first-page":"11419","DOI":"10.1158\/0008-5472.CAN-05-1271","article-title":"ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier","volume":"65","author":"Bronger","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/pr.58.2.3","article-title":"Multidrug resistance-associated proteins: expression and function in the central nervous system","volume":"58","author":"Dallas","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.toxlet.2015.04.005_bib0045","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1471-4159.2001.00066.x","article-title":"Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells","volume":"76","author":"De Girolamo","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejps.2005.11.002","article-title":"The role of transporters in drug interactions","volume":"27","author":"Endres","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/clpt.2010.11","article-title":"Regional P-glycoprotein activity and inhibition at the human blood?brain barrier as imaged by positron emission tomography","volume":"87","author":"Eyal","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"October (1\u20132)","key":"10.1016\/j.toxlet.2015.04.005_bib0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-4274(99)00142-3","article-title":"The effects of carbaryl and trichlorphon on differentiating mouse N2a neuroblastoma cells?","volume":"110","author":"Flaskos","year":"1999","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mam.2005.12.003","article-title":"RNA integrity and the effect on the real-time qRT-PCR performance","volume":"27","author":"Fliege","year":"2006","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejpb.2007.10.003","article-title":"Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system","volume":"69","author":"F\u00f6rster","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.toxlet.2015.04.005_bib0075","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbapap.2009.02.014","article-title":"A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function","volume":"1794","author":"Fung","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxlet.2015.04.005_bib0080","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo","volume":"183","author":"Goodell","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The pharmacokinetics and interactions of ivermectin in humans\u2013a mini-review","volume":"10","author":"Gonz\u00e1lez Canga","year":"2008","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.toxlet.2015.04.005_bib0090","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/jpet.107.135194","article-title":"Substrate-dependent effects of human ABCG1 coding polymorphisms","volume":"325","author":"Gow","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1046-2023(02)00079-8","article-title":"Dynamics of multidrug resistance: P-glycoprotein analyses with positron emission tomography","volume":"27","author":"Hendrikse","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.toxlet.2015.04.005_bib0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jps.22262","article-title":"Ivermectin interacts with human ABCG2","volume":"100","author":"Jani","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0105","first-page":"2849","article-title":"Increased penetration of paclitaxel into the brain by inhibition of P-glycoprotein","volume":"9","author":"Kemper","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13206-013-7308-3","article-title":"Genome-wide temporal responses of human neuroblastoma SH-SY5Y cells to MPP+ neurotoxicity","volume":"7","author":"Kim","year":"2013","journal-title":"BioChip J."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0090-9556(24)15253-1","article-title":"Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein","volume":"27","author":"Kwei","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/taap.1996.8086","article-title":"P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity","volume":"143","author":"Lankas","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.toxlet.2015.04.005_bib0125","first-page":"217","article-title":"Abamectin as a pesticide for agricultural use","volume":"59","author":"Lasota","year":"1990","journal-title":"Acta Leiden."},{"issue":"7","key":"10.1016\/j.toxlet.2015.04.005_bib0130","doi-asserted-by":"crossref","first-page":"e22429","DOI":"10.1371\/journal.pone.0022429","article-title":"Sensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transporters","volume":"6","author":"Lebedeva","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.toxlet.2015.04.005_bib0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cbi.2005.11.002","article-title":"Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)","volume":"159","author":"Lespine","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejps.2006.10.004","article-title":"Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship","volume":"30","author":"Lespine","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0150","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1471-4159.2010.06731.x","article-title":"Enhancing the GLP-1 receptor signalling pathway leads to proliferation and neuroprotection in human neuroblastoma cells","volume":"113","author":"Li","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0160","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cbpc.2009.05.016","article-title":"Inhibition of multidrug\/xenobiotic resistance transporter by MK571 improves dye (Fura 2) accumulation in crustacean tissues from lobster, shrimp, and isopod","volume":"150","author":"Luders","year":"2009","journal-title":"Comp. Biochem. Physiol. Toxicol. Pharmacol."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0165","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00204-007-0193-6","article-title":"Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans","volume":"81","author":"Macdonald","year":"2007","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00008571-200111000-00012","article-title":"Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene","volume":"11","author":"Mealey","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.toxlet.2015.04.005_bib0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1124\/dmd.108.022715","article-title":"Natural allelic variants of bovine ATP-binding cassette transporter ABCG2: increased activity of the Ser581 variant and development of tools for the discovery of new ABCG2 inhibitors","volume":"37","author":"Merino","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tips.2010.03.003","article-title":"Regulation of P-glycoprotein and other ABC drug transporters at the blood\u2013brain barrier","volume":"31","author":"Miller","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0185","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1016\/j.bmc.2007.07.024","article-title":"New functional assay of P-glycoprotein activity using Hoechst 33,342","volume":"15","author":"M\u00fcller","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0190","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2967\/jnumed.108.059162","article-title":"Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans","volume":"50","author":"Muzi","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0195","first-page":"481","article-title":"In vitro P-glycoprotein inhibition assay on N2A murine cell line","volume":"61","author":"Nicolae","year":"2013","journal-title":"Farmacia"},{"key":"10.1016\/j.toxlet.2015.04.005_bib0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","article-title":"Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain","volume":"129","author":"Nies","year":"2004","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.toxlet.2015.04.005_bib0205","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/sj.bjp.0703762","article-title":"Ivermectin excretion by isolated functionally intact brain endothelial capillaries","volume":"132","author":"Nobmann","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/34.2.195","article-title":"Ivermectin in human medicine","volume":"34","author":"Ottesen","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/jpet.103.049858","article-title":"Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity","volume":"306","author":"Potschka","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0006-2952(96)00656-9","article-title":"Reversal of P-glycoprotein-associated multidrug resistance by ivermectin","volume":"53","author":"Pouliot","year":"1997","journal-title":"Biochem. Pharmacol."},{"issue":"34","key":"10.1016\/j.toxlet.2015.04.005_bib0225","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/dmd.105.008615","article-title":"In Vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates","volume":"2006","author":"Rautio","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0230","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.clpt.2005.01.022","article-title":"Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography","volume":"77","author":"Sasongko","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.toxlet.2015.04.005_bib0235","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.fpc.0000230113.03710.34","article-title":"In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphisms","volume":"16","author":"Schaefer","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"issue":"2","key":"10.1016\/j.toxlet.2015.04.005_bib0240","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V99.2.507","article-title":"The ABCG2 transporter is an efficient Hoechst 33,342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors","volume":"99","author":"Scharenberg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.toxlet.2015.04.005_bib0245","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood\u2013brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.toxlet.2015.04.005_bib0250","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A","volume":"96","author":"Schinkel","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.toxlet.2015.04.005_bib0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-7-3","article-title":"RNA integrity number for assigning integrity values to RNA measurements","volume":"2006","author":"Schroeder","year":"2006","journal-title":"BMC Mol. Biol."},{"issue":"1","key":"10.1016\/j.toxlet.2015.04.005_bib0260","doi-asserted-by":"crossref","first-page":"e00109","DOI":"10.1002\/prp2.109","article-title":"Identification of trichlormethiazide as a Mdr1a\/b gene expression enhancer via a dual secretion-based promoter assay","volume":"3","author":"Schulze","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.toxlet.2015.04.005_bib0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1432-1033.1997.00115.x","article-title":"P-glycoprotein-mediated hoechst 33,342 transport out of the lipid bilayer","volume":"250","author":"Shapiro","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00207450108986509","article-title":"Neuroblastoma cell lines\u2014a versatile in vitro model in neurobiology","volume":"108","author":"Shastry","year":"2001","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0275","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2005.11.011","article-title":"Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood\u2013brain barrier","volume":"138","author":"Soontornmalai","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.toxlet.2015.04.005_bib0280","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.toxlet.2009.10.021","article-title":"Effects of avermectins on neurite outgrowth in differentiating mouse neuroblastoma N2a cells","volume":"192","author":"Sun","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0285","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/jps.20787","article-title":"Species differences of inhibitory effects on P-glycoprotein-mediated drug transport","volume":"96","author":"Suzuyama","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/bi00001a005","article-title":"Human (MDR1) and mouse (mdr1, mdr3) P-glycoprotein can be distinguished by their respective drug resistance profiles and sensitivity to modulators","volume":"34","author":"Tang-Wai","year":"1995","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.toxlet.2015.04.005_bib0295","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/0006-2952(93)90677-O","article-title":"Restricted transport of cyclosporin A across the blood\u2013brain barrier by a multidrug transporter, P-glycoprotein","volume":"46","author":"Tsuji","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0300","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jpsychires.2005.10.005","article-title":"Blood\u2013brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls","volume":"41","author":"Uhr","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0305","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1158\/1078-0432.CCR-07-1335","article-title":"P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan","volume":"13","author":"de Vries","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.toxlet.2015.04.005_bib0310","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkl474","article-title":"Modulation of human BCRP (ABCG2) activity by anti-HIV drugs","volume":"59","author":"Weiss","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0315","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1172\/JCI8267","article-title":"Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier","volume":"105","author":"Wijnholds","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.toxlet.2015.04.005_bib0320","first-page":"1086","article-title":"SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease","volume":"123","author":"Xie","year":"2010","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.toxlet.2015.04.005_bib0325","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0022-3565(24)38809-3","article-title":"In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results","volume":"296","author":"Yamazaki","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2015.04.005_bib0330","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1124\/dmd.108.024489","article-title":"The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice","volume":"37","author":"Zhou","year":"2009","journal-title":"Drug Metab. Dispos."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427415001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427415001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:09:49Z","timestamp":1747912189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427415001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0378427415001332"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2015.04.005","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}